Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial. - Wikidata - awgldk - TriplyDB

Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.

Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.

http://www.wikidata.org/entity/Q34666104

about

The clinical efficacy of artemether/lumefantrine (Coartem)Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria Artemisinin-based combination therapy for treating uncomplicated malaria The safety of amodiaquine use in pregnant women Utilization of insecticide-treated nets by under-five children in Nigeria: assessing progress towards the Abuja targets.Dynamic RNA profiling in Plasmodium falciparum synchronized blood stages exposed to lethal doses of artesunate.Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Malaria: an update on current chemotherapy.Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments.Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia.Knowledge, Attitudes, and Practices about Malaria and Its Control in Rural Northwest Tanzania.Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial.Multiple treatment comparisons in a series of anti-malarial trials with an ordinal primary outcome and repeated treatment evaluations.Artesunate Plus Amodiaquine (AS+AQ) Versus Artemether -Lumefantrine (AL) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Sub-Saharan Africa-A Meta-Analysis Is chloroquine better than artemisinin combination therapy as first line treatment in adult nigerians with uncomplicated malaria?-A cost effectiveness analysis Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in Calabar, Nigeria Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso.A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria.Artesunate-amodiaquine for the treatment of uncomplicated malaria.Evaluation of the efficacy and safety of artemether-lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in Nigerian infants and children.A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children.Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis Artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria.Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes.Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children.Artemether-Soluplus Hot-Melt Extrudate Solid Dispersion Systems for Solubility and Dissolution Rate Enhancement with Amorphous State Characteristics.

P2860

Q21034141-7E674236-3978-4C18-9075-BE9A66C96B0F Q21143739-D2BE28B0-4151-4170-97DD-FFCDA7697544 Q24241785-0D786C9D-EC81-40B5-B74B-4451A5CF86DD Q28255205-5E6E41A8-7137-45A6-A57A-ECB304391FBA Q30483617-6BA2992F-0DBE-4FD0-85E1-DA4EC031E591 Q33360465-409F8F3F-EE2C-40F2-937C-97CCCFC459C7 Q33635019-7A31308C-5C33-4974-95A3-141BAAB89BA9 Q34433106-2A5C0834-A6AE-4432-9DB2-ED2AC08093F7 Q35029488-A340A24A-0543-4C0A-9F90-DF7F9A36DFB9 Q35030048-E7C7E945-DEBC-4163-AE8C-369E8157EF1C Q35031900-C7573A52-8924-468B-A5F8-EF9B382B78A7 Q35052961-8CD93575-4342-42D2-8451-50134D306226 Q35649120-9ABA78C5-24FC-47A9-A7C4-885312FD4DE0 Q35746267-FEB8EF07-1DAE-4BA4-A9B9-936BCD1EB8FF Q35986306-C8EBBCB7-636F-419C-B463-9484CF0CA342 Q36394490-516A41A4-0E50-4B7F-A0DB-36A4C6624F03 Q36398146-10B2D9CE-871C-4BC5-B064-BFC239D690C6 Q36398162-6926BE68-012E-4E54-9D77-36FF722C5A08 Q36513276-498DD763-9651-4631-9D19-5FD9011FFA80 Q36606690-661D00B4-7B2D-4056-BE64-D0E2279F9731 Q36724458-D1D6091E-95D6-44FD-912C-EBBAE9294BD1 Q36861619-76A02660-1507-482D-86E8-35CBB412942B Q37037149-22D1D02B-041B-4C7D-BBBF-4918DD4E6F46 Q37059334-6FFAAEAB-AB35-4A6D-BB66-FCC336A56766 Q37350167-15602258-F44C-4F13-ABEF-2C0B19E5D915 Q37388596-99B4D91F-F0A9-4518-905A-4F6802606830 Q37423034-F576FDB4-97A4-47E8-BFAD-7B2106757E5E Q40210481-051644EC-CE37-4029-A73E-4F6E2A1BC61C Q40335976-2925E8DC-85D3-4670-BCFB-BCD7E0E72114

P2860

Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.

http://www.wikidata.org/entity/Q34666104

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Artemether-lumefantrine versus ...... : randomized controlled trial.

@ast

Artemether-lumefantrine versus ...... : randomized controlled trial.

@en

Artemether-lumefantrine versus ...... : randomized controlled trial.

@nl

type

label

Artemether-lumefantrine versus ...... : randomized controlled trial.

@ast

Artemether-lumefantrine versus ...... : randomized controlled trial.

@en

Artemether-lumefantrine versus ...... : randomized controlled trial.

@nl

prefLabel

Artemether-lumefantrine versus ...... : randomized controlled trial.

@ast

Artemether-lumefantrine versus ...... : randomized controlled trial.

@en

Artemether-lumefantrine versus ...... : randomized controlled trial.

@nl

P1433

Q34666104-204DC284-9772-450B-B1D0-2E2E819361E3

P1476

Q34666104-D5E39A4C-085B-49FC-8C55-BC4C2FF6C242

P2093

Q34666104-27CE58B3-883B-425E-98C6-91D29CC65D73

Q34666104-28EBC8E0-21C7-4531-9488-E148900A8561

Q34666104-46638F0C-A54E-4690-8416-C74CCAD9A621

Q34666104-6FA8B9F2-3281-4369-A4F8-D18205D244D5

Q34666104-79AB0316-6E32-45F9-8493-49336814EC30

Q34666104-87247D02-5A50-464B-A644-6FA84BA512C9

Q34666104-8D22C4A6-24D1-4F6D-A61C-689C92768EAB

Q34666104-984F3309-2703-4686-95D3-5B2956D1FDB3

P2860

Q34666104-262ABBCB-5301-4593-B23C-2F9D3255A802

Q34666104-34E19687-911E-445A-826E-9B71ABC3812B

Q34666104-48F57684-EC15-4545-870A-AF5CBD6708CE

Q34666104-511BE466-CDAF-4502-AFCC-BC66824F0614

Q34666104-5643E6B2-86FC-461A-B7B1-0670DC6AB2EF

Q34666104-5B44503C-0252-4029-90BC-97C96464F6AC

Q34666104-734D14D3-6FCE-4D67-953B-EF8229D2AF97

Q34666104-7E5A429E-8A9B-4DF4-82D1-AA8B693E2658

Q34666104-8C8AA73A-54BF-433F-B81F-78744500A823

Q34666104-92E7B4F2-9EA4-456A-95C9-7EAA3C07E17B

P2888

Q34666104-ECB7AC2D-DA5E-4869-8C33-590E124D7E39

P304

Q34666104-4CC909AB-F799-46EB-BF99-DC7BF05A6387

P31

Q34666104-40316589-516C-4EB9-910E-B0FD899EF0A6

P356

Q34666104-160FD4D3-4631-4892-8419-0CE656B47F19

P478

Q34666104-B8DC5F04-818A-4B34-B68B-8579B74A2CF8

P577

Q34666104-CFD85BF0-44FF-4F33-A963-D369592561F4

P5875

Q34666104-EF2350CE-196B-4AD1-97E9-7228B00E38D6

P6179

Q34666104-7475A726-AE31-4A4A-864C-71262D75FB71

P698

Q34666104-990E4DA8-DDA0-44AD-9A5C-5F4DE25F5ACF

P921

Q34666104-1C9B4368-BDEE-47C3-8B99-4216F1D2119D

Q34666104-7FD12EA1-6B2E-45ED-995F-DD0DB6A98297

Q34666104-EF9B9C8A-FBFF-462A-B4AE-DF94146C6DFE

Q34666104-F39F6EA2-E835-4181-857F-9211603548F0

P932

Q34666104-7442E3F2-32E8-4E7E-9AF3-50BF533C41C4

P356

P1433

Malaria Journal

P1476

Artemether-lumefantrine versus ...... : randomized controlled trial.

@en

P2093

Ambrose Alaribe

http://www.w3.org/2001/XMLSchema#string

Angela Oyo-Ita

http://www.w3.org/2001/XMLSchema#string

Chukwuemeka Nwachukwu

http://www.w3.org/2001/XMLSchema#string

Donald Ordu

http://www.w3.org/2001/XMLSchema#string

Emmanuel Ezedinachi

http://www.w3.org/2001/XMLSchema#string

John Ekenjoku

http://www.w3.org/2001/XMLSchema#string

Martin Meremikwu

http://www.w3.org/2001/XMLSchema#string

Regina Ejemot

http://www.w3.org/2001/XMLSchema#string

P2860

Artemether-lumefantrine for treating uncomplicated falciparum malaria

Making malaria-treatment policy in the face of drug resistance.

Delaying antimalarial drug resistance with combination chemotherapy.

Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria.

Artemisinin-based combinations.

Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.

Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.

Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.

Treatment of malaria in north-eastern and south-eastern Nigeria: a population study of mefloquine, sulphadoxine, pyrimethamine combination (MSP) vs chloroquine (CQ).

Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children.

P2888

P304

43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-5-43

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7076375

http://www.w3.org/2001/XMLSchema#string

P6179

1006436641

http://www.w3.org/2001/XMLSchema#string

P698

16704735

http://www.w3.org/2001/XMLSchema#string

P921

P932

1475595

http://www.w3.org/2001/XMLSchema#string